Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole Scobie

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Pediatric Blood & Cancer|April 4, 2022
To transplant, or not to transplant? That is the question. A patient advocate evaluation of autologous stem cell transplant in neuroblastomaNicholas Bird, Nicole Scobie, Antonia Palmer, et al.
Cancer Reports (Hoboken, N.J.)|August 12, 2021
Setting international standards for patient and parent involvement and engagement in childhood, adolescent and young adult cancer research: A report from a European Collaborative WorkshopAngela Polanco, Reem Al-Saadi, Suzanne Tugnait, et al.
European Journal of Cancer (Oxford, England : 1990)|August 19, 2017
Orphan Drug Regulation: A missed opportunity for children and adolescents with cancerGilles Vassal, Pam Kearns, Patricia Blanc, et al.
Cancer Medicine|October 23, 2021
Intercontinental collaboration in clinical trials for children and adolescents with cancer-A systematic review by ACCELERATETeresa de Rojas, Andrew J Pearson, Nicole Scobie, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2026
Eligibility criteria in pediatric oncology phase I and II clinical trials: Analysis and recommendations for standardization from the Innovative Therapies for Children and Adolescents with Cancer (ITCC) ConsortiumUri Ilan, Alba Rubio-San-Simón, Natasha van Eijkelenburg, et al.
Journal of the National Cancer Institute|November 17, 2023
Impact of ACCELERATE Paediatric Strategy Forums: a review of the value of multi-stakeholder meetings in oncology drug developmentAndrew D J Pearson, Teresa de Rojas, Dominik Karres, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2022
ACCELERATE - Five years accelerating cancer drug development for children and adolescentsAndrew D J Pearson, Susan L Weiner, Peter C Adamson, et al.
JAMA Network Open|December 6, 2024
Stakeholder Perspectives on Randomized Clinical Trials for Children With Poor-Prognosis CancersNicholas Bird, Nicole Scobie, Pablo Berlanga, et al.
JCO Precision Oncology|January 15, 2026
Pathway for the Development of ATR Inhibitors in Pediatric Malignancies: An ACCELERATE Multistakeholder AnalysisSusanne A Gatz, Julia Glade-Bender, Andrew D J Pearson, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2022
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Carl Allen, Jason Fangusaro, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Pediatric Blood & Cancer|April 4, 2022
To transplant, or not to transplant? That is the question. A patient advocate evaluation of autologous stem cell transplant in neuroblastomaNicholas Bird, Nicole Scobie, Antonia Palmer, et al.
Cancer Reports (Hoboken, N.J.)|August 12, 2021
Setting international standards for patient and parent involvement and engagement in childhood, adolescent and young adult cancer research: A report from a European Collaborative WorkshopAngela Polanco, Reem Al-Saadi, Suzanne Tugnait, et al.
European Journal of Cancer (Oxford, England : 1990)|August 19, 2017
Orphan Drug Regulation: A missed opportunity for children and adolescents with cancerGilles Vassal, Pam Kearns, Patricia Blanc, et al.
Cancer Medicine|October 23, 2021
Intercontinental collaboration in clinical trials for children and adolescents with cancer-A systematic review by ACCELERATETeresa de Rojas, Andrew J Pearson, Nicole Scobie, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2026
Eligibility criteria in pediatric oncology phase I and II clinical trials: Analysis and recommendations for standardization from the Innovative Therapies for Children and Adolescents with Cancer (ITCC) ConsortiumUri Ilan, Alba Rubio-San-Simón, Natasha van Eijkelenburg, et al.
Journal of the National Cancer Institute|November 17, 2023
Impact of ACCELERATE Paediatric Strategy Forums: a review of the value of multi-stakeholder meetings in oncology drug developmentAndrew D J Pearson, Teresa de Rojas, Dominik Karres, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2022
ACCELERATE - Five years accelerating cancer drug development for children and adolescentsAndrew D J Pearson, Susan L Weiner, Peter C Adamson, et al.
JAMA Network Open|December 6, 2024
Stakeholder Perspectives on Randomized Clinical Trials for Children With Poor-Prognosis CancersNicholas Bird, Nicole Scobie, Pablo Berlanga, et al.
JCO Precision Oncology|January 15, 2026
Pathway for the Development of ATR Inhibitors in Pediatric Malignancies: An ACCELERATE Multistakeholder AnalysisSusanne A Gatz, Julia Glade-Bender, Andrew D J Pearson, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2022
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Carl Allen, Jason Fangusaro, et al.
Pageof 3